Another firm issues recall of heparin
- Share via
B. Braun Medical Inc. recalled heparin blood thinner in the U.S. and Canada after learning that it contained a “heparin-like contaminant” from a supplier linked to deaths and allergic reactions in another company’s product.
The contaminant was supplied by Scientific Protein Laboratories, Irvine-based B. Braun Medical said Friday. Scientific Protein also supplied Baxter International Inc. with heparin containing a cheaper ingredient from China.
Baxter’s heparin has been linked to serious allergic reactions and 19 U.S. deaths. The heparin recalled by Braun is sold to hospitals as a premixed solution in intravenous drip bags, a Food and Drug Administration spokeswoman said.
Neither Braun nor the FDA was aware of anyone sickened by the recalled heparin.
B. Braun Medical is a unit of closely held B. Braun Melsungen of Melsungen, Germany.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
